全文获取类型
收费全文 | 5457篇 |
免费 | 320篇 |
国内免费 | 80篇 |
专业分类
耳鼻咽喉 | 48篇 |
儿科学 | 293篇 |
妇产科学 | 70篇 |
基础医学 | 579篇 |
口腔科学 | 366篇 |
临床医学 | 447篇 |
内科学 | 1563篇 |
皮肤病学 | 165篇 |
神经病学 | 216篇 |
特种医学 | 441篇 |
外科学 | 612篇 |
综合类 | 58篇 |
一般理论 | 1篇 |
预防医学 | 304篇 |
眼科学 | 76篇 |
药学 | 286篇 |
2篇 | |
中国医学 | 8篇 |
肿瘤学 | 322篇 |
出版年
2023年 | 22篇 |
2022年 | 37篇 |
2021年 | 116篇 |
2020年 | 63篇 |
2019年 | 115篇 |
2018年 | 143篇 |
2017年 | 99篇 |
2016年 | 87篇 |
2015年 | 116篇 |
2014年 | 146篇 |
2013年 | 187篇 |
2012年 | 201篇 |
2011年 | 262篇 |
2010年 | 212篇 |
2009年 | 215篇 |
2008年 | 198篇 |
2007年 | 279篇 |
2006年 | 212篇 |
2005年 | 229篇 |
2004年 | 203篇 |
2003年 | 186篇 |
2002年 | 189篇 |
2001年 | 173篇 |
2000年 | 203篇 |
1999年 | 146篇 |
1998年 | 173篇 |
1997年 | 187篇 |
1996年 | 157篇 |
1995年 | 120篇 |
1994年 | 131篇 |
1993年 | 107篇 |
1992年 | 90篇 |
1991年 | 91篇 |
1990年 | 92篇 |
1989年 | 100篇 |
1988年 | 83篇 |
1987年 | 68篇 |
1986年 | 72篇 |
1985年 | 64篇 |
1984年 | 31篇 |
1983年 | 24篇 |
1982年 | 26篇 |
1981年 | 32篇 |
1980年 | 27篇 |
1979年 | 10篇 |
1978年 | 15篇 |
1977年 | 20篇 |
1976年 | 26篇 |
1975年 | 22篇 |
1970年 | 8篇 |
排序方式: 共有5857条查询结果,搜索用时 15 毫秒
101.
102.
Castillo Laita JA De Benito Fernández J Escribano Montaner A Fernández Benítez M García de la Rubia S Garde Garde J García-Marcos L González Díaz C Ibero Iborra M Navarro Merino M Pardos Martínez C Pellegrini Belinchon J Sánchez Jiménez J Sanz Ortega J Villa Asensi JR 《Allergologia et immunopathologia》2008,36(1):31-52
103.
J. F. San Miguel M. Gonzáalez A. Gascón Ma J. Moro J. M. Hernáandez F. Ortega R. Jimenez L. Guerras M. Romero F. Casanova M. A. Sanz J. Sáanchez J. A. Portero A. Orfao 《British journal of haematology》1991,77(2):185-190
In 112 untreated myeloma patients we have analysed the immunophenotype of plasma cells both by immunofluorescence (IF) and immunocytochemistry (APAAP). Both techniques yielded similar results pointing to an important degree of heterogeneity in antigenic expression not only between different patients but also within the same patient. The expression of CD38 and Han-PC1 antigens (Ags) was almost constant (greater than 90% positive cases), while CD9 was detected in 66% of the cases. On the other hand, less than one third of patients were positive for CD10, CD20 and HLA-DR and generally with a weak expression (less than 30% positive plasma cells). In occasional cases plasma cells were weakly positive for the myelomonocytic markers CD13 (9%), CD15 (25%) and CD14 (6%). The possibility that this heterogeneity might be the result of different stages of differentiation of the neoplastic clone is suggested both by the positive correlation in the expression of some of these antigens (CD10, CD9, CD20, HLA-DR) and by the relationship between CD10 and myeloid antigens with immature plasma cell morphology. Finally, the cALLA antigen does not seem to be of significant value in predicting survival. Moreover, none of the other markers explored showed a clear influence in the course of the disease, although the tendency towards a lower survival found for the CD20+ cases as well as the association of the expression of some antigens and advanced clinical stage, may warrant further studies in a larger series of patients. 相似文献
104.
105.
106.
E. Martínez Chamorro T.Y. Revilla Ostolaza M. Pérez Núñez S. Borruel Nacenta C. Cruz-Conde Rodríguez-Guerra L. Ibáñez Sanz 《Radiologia》2021,63(1):13-21
IntroductionSARS-CoV-2, the virus responsible for the current pandemic, predominantly affects the respiratory tract, and a growing number of publications report the predisposition of patients with COVID-19 to develop thrombotic phenomena.ObjectiveTo determine the prevalence of pulmonary embolism in patients with COVID-19; to determine the possible relationship between the severity of pulmonary involvement and D-dimer levels; to analyze the location of pulmonary embolisms in patients with COVID-19 and to compare it with the location in patients without COVID-19.MethodsThis retrospective study analyzed all CT angiograms of the pulmonary arteries done in patients with suspected pulmonary embolisms between March 15 and April 30, 2020 and compared them with studies done in the same period one year earlier.ResultsWe included 492 pulmonary CT angiograms (342 (69.9%) in patients with COVID-19 and 147 (30.1%) in patients without COVID-19). The prevalence of pulmonary embolisms was higher in patients with COVID-19 (26% vs. 16.3% in patients without COVID-19, p=0.0197; relative risk=1.6). The prevalence of pulmonary embolisms in the same period in 2019 was 13.2%, similar to that of the group of COVID-19-negative patients in 2020 (p=0.43). There were no significant differences in D-dimer levels or the location of pulmonary embolisms between the two groups. CT showed moderate or severe pulmonary involvement in 78.7% of the patients with COVID-19.ConclusionsPatients with COVID-19 have an increased prevalence of pulmonary embolisms (26%), and most (78.7%) have moderate or severe lung involvement on CT studies. The location of pulmonary embolisms and the degree of elevation of D-dimer levels does not differ between patients with COVID-19 and those without. 相似文献
107.
Dolors Costa Concha Muoz Ana Carri Meritxell Nomdedeu Xavier Calvo Francesc Sol Elisa Luo Jos Cervera Teresa Vallespí Daniela Berneaga Cndida Gmez Amparo Arias Esperanza Such Guillermo Sanz Javier Grau Andrs Insunza María J. Calasanz María T. Ardaaz Jesús M. Hernndez Gemma Azaceta Sara lvarez Joaquín Snchez María L. Martín Joan Bargay Valle Gmez Carlos Javier Cervero María J. Allegue Rosa Collado Elias Campo Benet Nomdedeu 《Genes, chromosomes & cancer》2013,52(8):753-763
The infrequency of translocations in myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemias (CMML) makes their identification and reporting interesting for the recognition of the recurrent ones and the genes involved in these neoplasias. The aims of this study were to identify new translocations associated with MDS and CMML and to establish their frequency in a cohort of 8,016 patients from the Spanish Group of MDS database. The karyotype was evaluable in 5,654 (70%) patients. Among those, 2,014 (36%) had chromosomal abnormalities, including 213 (10%) translocations identified in 195 patients. The translocations were balanced in 183 (86%) cases and unbalanced in 30 (14%) cases. All chromosomes were found to be involved in translocations, with the single exception of the Y chromosome. The chromosomes most frequently involved were in decreasing frequency: 3, 1, 7, 2, 11, 5, 12, 6, and 17. Translocations were found in karyotypes as the unique chromosomal abnormality (33%), associated with another chromosomal abnormality (11%), as a part of a complex karyotype (17%), and as a part of a monosomal karyotype (38%). There were 155 translocations not previously described in MDS or CMML and nine of them appeared to be recurrent. © 2013 Wiley Periodicals, Inc. 相似文献
108.
Sanz-Martín Ignacio Paeng Kyeongwon Park Hyobin Cha Jae-Kook Jung Ui-Won Sanz Mariano 《Clinical oral investigations》2021,25(6):3589-3597
Clinical Oral Investigations - To assess the efficacy of three mechanical decontamination methods in four types of commercially available implants. Ninety-six implants of four commercial brands... 相似文献
109.
110.